NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
Detailed price information for Nkgen Biotech Inc (NKGN-Q) from The Globe and Mail including charting and trades.
Microchip Extends maXTouch® M1 Generation Family to Support Large, Curved and Shaped Automotive Displays
Detailed price information for Microchip Technology (MCHP-Q) from The Globe and Mail including charting and trades.
gut.bmj5d
Gut microbiota-related neuroinflammation at the crossroad of food reward alterations: implications for eating disorders
The link between gut microbiome and eating behaviours, especially palatable food intake, is a growing focus of scientific ...
Researchers create new compound to potentially treat negative and positive symptoms of schizophrenia
We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea, for example. These ...
Zacks.com on MSN11d
MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?
Medtronic plc MDT is scheduled to report third-quarter fiscal 2025 results on Feb. 18, before the opening bell. See the Zacks Earnings Calendar to stay ahead of market-making news. In the last ...
Mint20d
India’s energy transition push continues with Nuclear Energy Mission, clean tech manufacturing
The union budget for FY26 continued with the government's emphasis on energy transition announcing a Nuclear Energy Mission with an outlay of ₹20,000 crore for research and development of small ...
STAT29d
Q&A: Why low oxygen shows potential as therapy for some chronic diseases
Oxygen is the breath of life, right? Because it keeps our bodies and organs from functioning as they should, supplemental oxygen helps when chronic lung disease or respiratory illness hamper ...